Cardiff Oncology, Inc. (CRDF) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cardiff Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.069 -- 00:00:04.671 Welcome to the Cardiff Oncology fourth quarter and full year 2023 financial results and 00:00:04.671 -- 00:00:09.733 corporate update conference call. At this time, all participants are in listen-only mode. 00:00:09.733 -- 00:00:13.335 After the speaker's presentation, there will be a question and answer session. 00:00:13.335 -- 00:00:17.617 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:17.617 -- 00:00:21.119 You will then hear an automated message advising your hand is raised. 00:00:21.119 -- 00:00:23.600 Please be advised that today's conference is being recorded. 00:00:23.600 -- 00:00:27.682 I would now like to turn the conference over to Lawrence Watts of the Gilmartin Group. 00:00:27.682 -- 00:00:30.022 Please go ahead. 00:00:30.168 -- 00:00:31.989 Thank you, Operator. 00:00:31.989 -- 00:00:35.712 Joining us on the call today from the Department of Oncology are Chief Executive Officer, 00:00:35.712 -- 00:00:40.576 Mark Erlander, Chief Medical Officer, Dr. Farooz Kabinova, and Chief Financial Officer, 00:00:40.576 -- 00:00:42.836 Jamie Levine. 00:00:43.458 -- 00:00:46.721 During this conference call, management will make forward-looking statements, including, 00:00:46.721 -- 00:00:51.324 without limitation, statements related to guidance, results, and the timing of data readouts 00:00:51.324 -- 00:00:54.247 for on-ventative clinical trials. 00:00:54.247 -- 00:00:57.369 These forward-looking statements are based on the company's current expectations and 00:00:57.369 -- 00:01:00.876 inherently involve significant risks and uncertainties. 00:01:00.876 -- 00:01:04.719 Our actual results and the timing of events could differ materially from those anticipated 00:01:04.719 -- 00:01:09.52...